Brandywine Global Investment Management, LLC Cara Therapeutics, Inc. Transaction History

Brandywine Global Investment Management, LLC

  • $13 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$2.83 - $4.94 $849 - $1,482
-300 Reduced 0.69%
43,036 $121,000
Q3 2022

Nov 14, 2022
SELL
$8.24 - $12.56 $13,711 - $20,899
-1,664 Reduced 3.7%
43,336 $406,000
Q2 2022

Aug 11, 2022
SELL
$7.45 - $13.84 $49,170 - $91,344
-6,600 Reduced 12.79%
45,000 $411,000
Q4 2021

Feb 11, 2022
SELL
$11.99 - $18.14 $201,276 - $304,516
-16,787 Reduced 24.55%
51,600 $628,000
Q3 2021

Nov 12, 2021
BUY
$11.55 - $16.06 $789,869 - $1.1 Million
68,387 New
68,387 $1.06 Million

Others Institutions Holding CARA

# of Institutions
88
Shares Held
16.5M
Call Options Held
55K
Put Options Held
500
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $16.1M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email